Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty

NCT ID: NCT02230826

Last Updated: 2025-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2044-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Outcome data collected from this study will be used for Post Market Surveillance (PMS) and Clinical Evaluations on Corin hip devices and will support peer-reviewed publications on products performance and safety at long term follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Replacement Primary, Secondary or Post-traumatic Osteoarthrosis Femur Head Necrosis Congenital Dislocations Primary and Revision Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Hip arthroplasty

Patients with Hip implants.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or woman \>18 years
* Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
* Subjects who agreed for study participation.

Exclusion Criteria

* Subjects with existing tumour and/or particularly high surgical risk-
* Subjects with anaesthetic risk class IV or higher
* Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
* Contraindications for arthroplasty with a Corin hip devices as per product IFU
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Corin

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Goulven Rochcongar, MD

Role: STUDY_CHAIR

University Hospital, Caen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Bordeaux - Groupe Hospitalier Pellegrin

Bordeaux, , France

Site Status ACTIVE_NOT_RECRUITING

clinique Oxford Cannes

Cannes, , France

Site Status TERMINATED

CH Dunkerque

Dunkirk, , France

Site Status TERMINATED

Polyclinique Henin Beaumont

Hénin-Beaumont, , France

Site Status RECRUITING

CHU de Nice

Nice, , France

Site Status RECRUITING

Centre Hospitalier Régionnal d'Orléans - Site La Source

Orléans, , France

Site Status TERMINATED

Clinique Arago

Paris, , France

Site Status TERMINATED

Hôpital de la Croix Saint-Simon

Paris, , France

Site Status RECRUITING

Hopital privé Saint-Martin

Pessac, , France

Site Status ACTIVE_NOT_RECRUITING

Hôpital Provo

Roubaix, , France

Site Status RECRUITING

Polyclinique St Georges de Didonne

Saint-Georges-de-Didonne, , France

Site Status RECRUITING

Médipôle Garonne

Toulouse, , France

Site Status TERMINATED

Hôpital Jean Bernard

Valenciennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vanessa Grimaud

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Romain GALMICHE, MD

Role: primary

Régis BERNARD DE DOMPSURE, MD

Role: primary

Antoine MOUTON, MD

Role: primary

François GIRAUD, MD

Role: primary

Christine LAUTRIDOU, MD

Role: primary

Charles BERTON, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1302-T-HIPLTO-RM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prospective G7 Dual Mobility Total Hip PMCF
NCT03308929 ACTIVE_NOT_RECRUITING
CoMplete™ Acetabular Hip System
NCT01543230 TERMINATED NA